Completed PHASE2/PHASE3 INTERVENTIONAL 5-arm NCT00922636

A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder

A Fixed-Dose, Randomized, Double-Blind, Placebo-Controlled Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder

Sponsor: Eli Lilly and Company

Conditions Attention Deficit Hyperactivity Disorder

Interventions LY2216684 Methylphenidate Placebo (capsule) Placebo (tablet)

Updated 7 times since 2017 Last updated: Jul 29, 2014 Started: Jun 30, 2009 Primary completion: Dec 31, 2010 Completion: Dec 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Attention Deficit Hyperactivity Disorder, this trial is completed. The trial is conducted by Eli Lilly and Company and has accumulated 7 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Dec 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jan 2021 — Dec 2021 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2_PHASE3

First recorded

Jun 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Eli Lilly and Company

Data source: Eli Lilly and Company

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bradenton, United States , Canton, United States , Gainesville, United States , Herndon, United States , Indianapolis, United States , Kelowna, Canada , Lake Jackson, United States , Las Vegas, United States , Lincoln, United States , Lubbock, United States and 9 more locations